(LGND) Ligand Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Ligand Pharmaceuticals | (LGND) share price targets
Complete technical analysis of Ligand Pharmaceuticals (LGND) by charts plus indicators, forecast predictions and share price targets for Ligand Pharmaceuticals (LGND)
Ligand Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Ligand Pharmaceuticals is 66580
Date | Daily Closing Price | Open | High | Low | Volume |
10 Mon Feb 2025 | 114.12 | 115.12 | 115.75 | 113.03 | 0.798 times |
07 Fri Feb 2025 | 115.19 | 117.04 | 118.64 | 113.92 | 1.027 times |
06 Thu Feb 2025 | 117.84 | 117.36 | 119.26 | 116.33 | 0.966 times |
05 Wed Feb 2025 | 117.31 | 117.92 | 119.11 | 116.49 | 1.078 times |
04 Tue Feb 2025 | 117.26 | 114.12 | 117.39 | 113.91 | 0.658 times |
03 Mon Feb 2025 | 114.76 | 113.76 | 116.51 | 113.27 | 0.855 times |
31 Fri Jan 2025 | 116.55 | 117.85 | 119.38 | 115.00 | 1.021 times |
30 Thu Jan 2025 | 118.64 | 120.00 | 122.34 | 118.22 | 1.104 times |
29 Wed Jan 2025 | 118.92 | 117.48 | 119.46 | 116.36 | 1.226 times |
28 Tue Jan 2025 | 118.11 | 117.33 | 118.43 | 115.98 | 0.787 times |
My analysis of stock is bearish for shortterm, and stock might move down till 112.3 or till 108.8. Use a stoploss of 115.17 and if the stock hits stoploss, then it can shoot up till 118.08
Share price targets for Ligand Pharmaceuticals (LGND)
Target Type | Value |
Downside Target | 97.78 |
Downside Target | 102.79 |
Downside Target | 105.00 |
Downside Target | 110.88 |
Upside Target | 115.75 |
Upside Target | 119.00 |
Upside Target | 119.26 |
Upside Target | 122.34 |
Upside Target | 125.50 |
Upside Target | 129.90 |
Intraday share price targets for Ligand Pharmaceuticals (LGND)
Target Type | Value |
Downside Intraday Target | 112.85 |
Downside Intraday Target | 111.58 |
Upside Intraday Target | 115.57 |
Upside Intraday Target | 117.02 |
Upside Intraday Target | 114.3 |
Weekly technical analysis of Ligand Pharmaceuticals (LGND)
Date | Weekly Closing Price | Open | High | Low | Volume |
10 Mon Feb 2025 | 114.12 | 115.12 | 115.75 | 113.03 | 0.174 times |
07 Fri Feb 2025 | 115.19 | 113.76 | 119.26 | 113.27 | 0.846 times |
31 Fri Jan 2025 | 116.55 | 114.75 | 122.34 | 114.75 | 0.96 times |
24 Fri Jan 2025 | 115.03 | 113.01 | 119.00 | 112.50 | 4.653 times |
17 Fri Jan 2025 | 111.89 | 111.08 | 113.20 | 110.88 | 0.159 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ligand Pharmaceuticals (LGND)
Date | Monthly Closing Price | Open | High | Low | Volume |
10 Mon Feb 2025 | 114.12 | 113.76 | 119.26 | 113.03 | 0.186 times |
31 Fri Jan 2025 | 116.55 | 108.12 | 122.34 | 102.79 | 0.841 times |
31 Tue Dec 2024 | 107.15 | 124.78 | 125.50 | 105.00 | 0.789 times |
26 Tue Nov 2024 | 124.33 | 107.05 | 129.90 | 107.05 | 1.406 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ligand Pharmaceuticals (LGND)
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term but the sell signal is initial and weak.
Ligand Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Ligand Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Ligand Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 116.98 and Ligand Pharmaceuticals (LGND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term but the sell signal is initial and weak.
Ligand Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Ligand Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Ligand Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 116.98 and Ligand Pharmaceuticals (LGND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.